Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis B news

Show

From To
Chronic hepatitis B infection associated with twice the risk of liver-related death compared to hepatitis C

The risk of death due to liver disease is twice as high for patients with chronic hepatitis B infection compared to individuals with chronic hepatitis C, US

Published
27 April 2012
By
Michael Carter
Telbivudine cuts mother-to-infant hepatitis B transmission

Telbivudine taken during the second or third trimester of pregnancy reduced the mother-to-infant transmission of hepatitis B to zero in an open-label trial of 88 women who had high viral loads and elevated alanine aminotransferase levels, Dr. Calvin Q. Pan and his colleagues reported in the May issue of Clinical Gastroenterology and Hepatology.

Published
16 April 2012
From
Family Practice News
Antiretroviral rollout provides a model for efforts to expand hepatitis C treatment and care in resource-limited settings

The rollout of antiretroviral therapy in resource-limited settings provides a model for efforts to increase access to hepatitis C treatment and care in similar settings, investigators argue

Published
27 March 2012
By
Michael Carter
Hepatitis C surpasses HIV as a cause of death in the US

Deaths in the US due to hepatitis C now exceed those caused by HIV, according to research published in the Annals of Internal Medicine.  The study

Published
21 February 2012
By
Michael Carter
Statins May Stave Off Liver Cancer in People With Hepatitis B

Study found lower risk of developing disease for people taking these cholesterol-cutting drugs

Published
30 January 2012
From
Health Day
Studies from US and Spain show that hepatitis vaccination programmes not reaching target populations

The majority of US adults at risk of hepatitis B remain unvaccinated against the potentially life-threatening infection of hepatitis, according to research published in advance of print

Published
23 January 2012
By
Michael Carter
France: Is more frequent monitoring for liver cancer among co-infected people needed?

This study suggests that liver cancer occurs earlier and is more extensive in some co-infected people who are at high risk for liver cancer. If the French findings are confirmed, increased medical monitoring of co-infected people at high risk for liver cancer may be necessary.

Published
11 January 2012
From
CATIE
Co-infection with hepatitis B worsens HIV-related outcomes

Co-infection with hepatitis B virus increases the risk of AIDS or death for patients newly diagnosed with HIV, investigators from the US military report in the online edition

Published
13 December 2011
By
Michael Carter
Hepatitis B genotype B associated with poorer liver-related outcomes in Taiwanese patients co-infected with HIV and hepatitis B

Liver-related outcomes are poorer in HIV-positive patients who are co-infected with hepatitis B virus genotype B compared to co-infected patients with hepatitis B genotype C, Taiwanese investigators

Published
13 December 2011
By
Michael Carter
Hep C deaths outpace HIV; new drugs, services for coinfected

Deaths related to hepatitis C have outpaced those due to HIV/AIDS since 2007, researchers reported at the American Association for the Study of Liver Diseases meeting earlier this month in San Francisco.

Published
23 November 2011
From
Bay Area Reporter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.